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Abstract
Objective
Coeliac disease (CD) is a chronic autoimmune disease of the small intestine caused by the ingestion of gluten, in which 
musculoskeletal manifestations may occur. Aim of this study was to evaluate the prevalence and severity of joint 
involvement in paediatric patients with CD using musculoskeletal ultrasound (US). 
Methods
Consecutive paediatric CD patients were enrolled and underwent US evaluations at level of knees, hips and ankles. 
The presence of joint effusion (JE), synovial hypertrophy, power Doppler signal and structural damage lesions (bone 
irregularities and erosions) was registered. Inflammatory abnormalities were scored on a semi-quantitative scale (0–3), 
and structural damage lesions on a dichotomous scale (0–1).
Results
Seventy-four CD children (mean age: 7.6 years; range: 1–14.2; M/F 24/50) were enrolled. Thirty-eight were on a 
gluten-containing diet (GCD) and 36 on a gluten-free diet (GFD). US showed the presence of abnormalities in 23 patients 
overall (31.1%); JE was the most frequently observed change (23/23). US abnormalities were observed in 19 patients 
(50.0%) of GCD group and in 4 of GFD group (11.1%, p=0.007). Interestingly, 12/23 (52.2%) patients with US-detected 
changes were asymptomatic.
Conclusion
This is the first US study demonstrating joint involvement in children with CD. JE, the most frequent manifestation, was 
present also in asymptomatic patients and was reduced in those on GFD. These findings may indicate that, also at joint 
level, an inflammatory response represented by the appearance of JE may be induced by exposure to gluten. 
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Introduction
Coeliac disease (CD) is a chronic auto-
immune disease of the small intestine 
caused by ingestion of gluten. In geneti-
cally susceptible individuals, carrying 
the DQA1*05-DQB1*02 or DQA1*03-
DQB1*0302 alleles, the intestine expo-
sure to gluten induces an inflammatory 
response, which leads to crypt hyperpla-
sia and villous atrophy of the small bow-
el mucosa, pathological markers of the 
disease (1, 2). Based on published stud-
ies, the prevalence of the disease in the 
American and European population is 
approximately 1%. However, such prev-
alence could be underestimated because 
of those atypical or even silent forms 
which remain undiagnosed (3, 4). The 
classic form of CD in children consists 
of gastrointestinal symptoms (such as 
diarrhea or constipation, vomiting and 
abdominal pain); however, a number of 
cases is characterised by later-onset and 
atypical symptoms with extra-intestinal 
manifestations (5). In these patients, 
musculoskeletal manifestations, char-
acterised by arthralgias, myopathies and 
non-erosive arthritis, may occur. To the 
best of our knowledge, at present data 
concerning the musculoskeletal involve-
ment in children affected by CD are 
scarce (6-9). Both in adult and children 
pathology, musculoskeletal ultrasound 
(US) has played an increasing role in 
the assessment of patients with differ-
ent rheumatic diseases, demonstrating 
its ability to detect a wide set of inflam-
matory and structural abnormalities (10-
12). As for adults, the superiority of US 
over clinical examination in the detec-
tion of joint inflammatory status was 
demonstrated in children, allowing for 
the re-classification of oligoarticular on 
polyarticular disease subsets. Moreover, 
US allowed earlier assessment of carti-
lage and bone abnormalities than con-
ventional radiology (13). 
Based on the lack of data on the use of 
US in assessing patients with CD, the 
aim of the present study was to evaluate 
the prevalence and severity of joint in-
volvement in a group of paediatric CD 
patients by using US. In addition, we 
compared the data obtained in the pa-
tient group on a gluten-containing diet 
(GCD) with those from the group on a 
gluten-free diet (GFD).
Methods
During a 22-month period (from May 
2009 to March 2011), children affected 
by CD, referring to the Departmental 
Operative Unit “Celiachia e Patologie 
da Malassorbimento” of the Paediatric 
Department at Sapienza Università di 
Roma, were enrolled in our study. Spe-
cifically, we enrolled all children with 
a new diagnosis on GCD (group 1), 
and children with a previous diagnosis 
of CD, on a GFD for at least 6 months 
(group 2).
A history of injury in the previous 2 
weeks and the presence of concomitant 
rheumatic diseases were considered 
exclusion criteria from the study.
Gastroenterological evaluation
At the time of diagnosis, all children 
performed laboratory analysis (to-
tal serum IgA [commercial kits]; IgA 
and IgG anti-endomisium antibodies 
[EMA, IFI on monkey esophagus]; 
IgA and IgG anti-transglutaminase 
antibodies [tTGAb; ELISA, Menarini, 
Firenze, Italy]) and underwent upper 
endoscopy (Olympus PQ20 or GIF-E, 
or GIF-P140 gastroscope), to obtain at 
least 2 samples from bulb mucosa and 
4 from distal duodenum. The histologi-
cal lesions of the small intestinal mu-
cosa were evaluated according to the 
Marsh classification, as modified by 
Oberhuber et al. (14). The diagnosis 
of CD was performed according to the 
North American Society for Paediatric 
Gastroenterology, Hepatology and Nu-
trition (NASPGHAN) criteria (15). 
Rheumatologic evaluation
The rheumatologic assessment was 
conducted at the Rheumatology Unit of 
the Dipartimento di Medicina Interna e 
Specialità Mediche - Sapienza Univer-
sity of Rome. 
On the same day of the ultrasono-
graphic examination, children were 
evaluated by a single rheumatologist 
who made the clinical history and 
performed physical examination. The 
medical history included registration 
of musculoskeletal symptoms, such 
as arthritis and/or arthralgia or lim-
ited motion, patient’s sport activities, 
co-morbidities and familiarity for any 
rheumatic diseases and psoriasis. The 
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medical history included the registra-
tion of recent joint injures (i.e. acciden-
tal trauma). Physical examination in-
cluded the analysis of joint tenderness, 
swelling and joints deformities, with 
focus particularly on the hip, knees and 
ankles joints. The rheumatologist was 
unaware of the type of diet followed by 
the patient.
Ultrasonographic assessment
US imaging was performed in all 
children, by using a Logiq 9 machine 
(General Electric, Medical Systems, 
Milwaukee, WI, USA), equipped with 
a 9–14 MHz linear array transducer, 
operating at 14 MHz frequency (gain 
50%). In addition, for the evaluation 
of local pathological hypervasculari-
sation, power Doppler (PD) was used, 
with the following settings: frequency 
7.5 MHz, gain 50%, PRF 0.5 kHz. 
According to the EULAR guidelines 
for US in rheumatology, in all children 
bilateral US evaluation of the hip, knee 
and ankle joints was performed by a 
single rheumatologist who was experi-
enced in paediatric musculoskeletal US 
and was blinded to patients’ laboratory 
and clinical features (16). The choice to 
evaluate these joints was in agreement 
with literature data, indicating that hip, 
knee and ankle are the most frequently 
involved in adult CD patients. 
According to the international defini-
tions currently in use, the presence of 
joint effusion (JE) and synovial hy-
pertrophy (SH) was registered: JE was 
defined as an abnormal hypoechoic or 
anechoic intraarticular material that 
is displaceable and compressible, but 
does not exhibit Doppler signal; SH as 
an abnormal hypoechoic intraarticu-
lar tissue that is non-displaceable and 
poorly compressible and which may 
exhibit Doppler signal (17).
Moreover, we evaluated the bone pro-
file, identifying the presence of bone 
irregularities (defined as loss of the 
continuous sharp hyper-echoic line of 
the bony cortex, with no evidence of 
erosion), and of erosions, defined as 
intra-articular discontinuities of the 
bone surface visible in 2 perpendicu-
lar planes (17). All abnormalities were 
scored on a 4-point semi-quantitative 
scale (0=absent; 1=mild; 2=moderate; 
3=severe), except for bony cortex ir-
regularities, which were scored on a 
dichotomous scale (present/absent). In 
addition, with the aim of assessing the 
intraobserver reliability, stored images 
of patients were re-evaluated by the 
same ultrasonographer 3 months after 
the end of the study.
Statistical analysis 
Statistical analysis was performed us-
ing the Statistical Package for Social 
Sciences 13.0 (SPSS, Chicago, IL, 
USA) and GraphPad 5.0 (La Jolla, CA, 
USA). Normally distributed variables 
were summarised using the mean±SD, 
and non-normally distributed variables 
by the median and range. Wilcoxon’s 
matched pairs test and paired t-test 
were performed. Univariate compari-
sons between nominal variables were 
calculated using chi-square (χ2) test or 
Fisher test where appropriate. 
The level of agreement, by using the 
Kappa Cohen coefficient, was defined 
as follows: ≤0.20 poor, 0.21–0.40 fair, 
0.41–0.60 moderate, 0.61–0.80 good, 
and 0.81–1.00 almost perfect (18).
Two-tailed p-values were reported, 
while p-values less than or equal to 
0.05 were considered significant. The 
local ethical committee approved the 
study, which was performed according 
to the Declaration of Helsinki criteria.
Results
Seventy-four children and adolescents 
(mean age: 7.6 years; range: 1-14.2; 
M/F 24/50) were enrolled. Thirty-eight 
children were classified for inclusion in 
group 1 and 34 in group 2. 
Clinical, histological and US results 
are reported in Tables I and II. Chil-
dren on GFD were older than those on 
GCD (9.2±6.7 versus 6.9±4.4; p=0.03). 
Patients in group 2, at the time of US 
assessment, had been assuming GFD 
for a period of 47.4±34.4 months. No 
other significant difference was found 
between the two groups of children re-
garding the clinical presentation of CD 
(typical, atypical or silent) (Table I). 
Among patients of group 1, all but one 
(97.3%) were positive for IgA tTGAb, 
and 34 out of the 37 patients (91.9%) 
tested positive for IgA EMA. Only 1 
patient (0.03%) resulted to have a par-
Table I. Clinical, histological and US features of CD patients. 
 GCD GFD p-value  GCD  p-value
 (n=38) (n=34) 
    Children with US  Children without US
    abnormalities (n=18)   abnormalities (n=20) 
Sex (M/F) 10/27 11/23 NS 6/12 5/15 NS
Mean age±SD 6.9±4.4 9.2±6.7 0.03 7.5±4.1 6.2±4.6 NS
CD Clinical form Typical (n/%) 26/68.4 26/76.5 NS 12/66.6 16/80.0 NS
 Atypical (n/%) 4/10.5 3/8.8 NS 2/11.1 2/10.0 NS
 Silent (n/%) 6/15.8 5/14.7 NS 4/22.2 2/10.0 NS
Arthralgia, n/% 7/18.4 5/14.7 NS 6/33.3 1/5.0 0.02
Diffusion of histological lesions¥ Diffuse (n/%) 34/91.9 30/88.2 NS 15/88.2* 19/95.0 NS
 Patchy (n/%) 1/ 2.7 0 NS 1/5.8* 0 NS
 Bulb (n/%) 2/ 5.4 0 NS 1/5.8= 1/5.0 NS
¥One patient in the GCD group and 4 patients in the GFD group could not be histologically characterised.
*One patient among children with US abnormalities had a potential CD.
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tial IgA deficiency, and tested positive 
for both IgG tTGAb and IgG EMA. In 
group 2, all patients were antibody-
negative. The demographic and clinical 
features of group 1 CD patients accord-
ing to the presence of US abnormalities 
are reported in Table I. 
US assessment showed the presence 
of at least one US abnormality in 23 
CD patients (31.1%). JE present at any 
level (knee, hip or ankle) was the most 
frequent abnormality observed (23/23, 
100% of patients with US involve-
ment) and it was mild in all cases. 
At least one US abnormality was ob-
served in 19 (50.0%) children of group 
1 and in 4 (11.1%) of group 2 (p=0.007). 
When evaluating the US-detected joint 
involvement, 36/228 joints (15.8%) 
showed at least one abnormality in 
children of group 1, compared to 5/216 
(2.3%) of group 2 (p<0.0001). When 
considering the different joint sites, the 
most frequently involved joint was the 
knee (Table II, Fig. 1): 14/38 (36.8%) 
children of group 1 showed US ab-
normalities at knee level, compared to 
4/36 of group 2 (11.1%). Mild JE was 
detected in 14 children (22 joints) of 
group 1 and in 4 (5 joints) children of 
group 2, with a significant difference 
between the two groups (p=0.01 when 
considering the number of children, 
p=0.005 when analysing the number of 
joints). 
At the level of the hip joint, JE was the 
only detected abnormality and it was 
found in a higher percentage of chil-
dren of group 1 compared with group 2 
(5/38 patients [13.2%] - 7 joints, versus 
0/36, [0%] p=0.02). No significant dif-
ferences were detected when analysing 
the ankle joint. At this level, the only 
pathologic finding was JE, which was 
detected in 3/38 (7.9%) children (4 
joints) of group 1 and in none (0%) of 
group 2. No significant association was 
found between the histological modifi-
cations or clinical presentation of CD 
and US abnormalities, when subgroup-
ing the patients according with the 
presence of US abnormalities. Clini-
cal evaluation demonstrated that 6/38 
(15.8%) patients of group 1 and 5/36 
(13.9%) of group 2 referred arthralgia, 
which was present only in patients who 
also had US-detected abnormalities. 
Finally, 12/23 (52.2%) of the patients 
with US detected abnormalities were 
asymptomatic.
No difference in terms of the severity of 
US detectable pathological findings was 
found between symptomatic and asymp-
tomatic patients: in all the cases, the US 
alterations were classified as mild. 
Intraobserver reproducibility assess-
ment showed kappa’s values of 0.8 and 
1 for the SE and SH, respectively.
Discussion
To the best of our knowledge, this is 
the first ultrasonographic study focused 
on the analysis of joint involvement in 
children affected by CD. We demon-
strated that US-detected joint abnor-
malities are more frequent in paediatric 
CD patients on GCD than in children 
on GFD, particularly with the evidence 
of subclinical joint effusion involving 
the knee. Musculoskeletal manifesta-
tions, characterised by arthralgia and 
non-erosive arthritis, with axial or pe-
ripheral asymmetrical involvement, 
can occur in patients affected by CD. 
Published studies about this topic, 
principally case reports or case series, 
documented a wide spectrum of mus-
culoskeletal manifestations. Bourne et 
al. described 6 CD patients showing 
arthralgia, mainly involving shoulders, 
hips, knees and ankles (6). Interest-
ingly, the onset of arthralgia preceded 
the diagnosis of CD and improved af-
ter  starting GFD (6). More recently, 
two different reports separately have 
described clinical cases of silent CD 
presenting with unusual polyarthri-
Table II. US abnormalities detected in the knee joint.
   
US features Patients Joints 
 
 GCD GFD p-value GCD GFD p-value
 n=38 (%) n=36 (%)  n=76 (%) n=72 (%) 
Total US abnormality 14 (36.8) 4 (11.1) 0.0005 22 (28.9) 5 (6.9) 0.0002
Synovitis
    JE (n/%) 14 (36.8) 4 (11.1) 0.0005 22 (28.9) 5 (6.9) 0.0002
    SH (n/%) 3 (7.9) 0  NS 3 (3.9) 0  NS
    PD (n/%) 1 (2.6) 0  NS 1 (1.3) 0  NS
Structural lesions
   Bone irregularities 0  0  NS 0  0  NS
   Erosions 0  0  NS 0  0  NS
Fig. 1. Suprapatellar scan of the knee: presence of mild synovial effusion (*) and hypertrophy (°).
^ epyphiseal plate. 
141
PAEDIATRIC RHEUMATOLOGYSubclinical synovitis in coeliac disease / A. Iagnocco et al.
tis (19, 20). Moreover, in 1996 Lu-
brano et al. evaluated musculoskeletal 
involvement in a large population of 
200 adult patients with established CD. 
Twenty-six percent of these evaluated 
patients showed arthritis, presenting as 
an asymmetrical olygoarthritis in 36% 
of cases, affecting mainly shoulders, el-
bows, knees or ankles (21). Sacroileitis 
was detected in 29% of patients, gen-
erally unilateral (80%) (21). However, 
joint involvement has been evaluated 
only in adult CD patients and mainly 
by using clinical assessment and/or 
conventional radiography, so far. 
In our study, we aimed at evaluating 
musculoskeletal involvement in a pae-
diatric CD population through the use 
of US. This is an emerging imaging 
modality that has acquired an increas-
ing role over the last years in the as-
sessment and monitoring of rheumatic 
diseases (22, 23). US allows for a de-
tailed depiction of the joint under in-
vestigation, providing information both 
on joint structures and peri-articular tis-
sues (10). It has been mainly applied in 
adult patients, so far, for analysing vari-
ous aspects of rheumatic diseases and 
its emerging role has been highlighted 
also in recently published classification 
criteria for specific disorders (24-29). 
However, recently published studies 
have confirmed its relevant role also in 
the diagnosis and assessment of mus-
culoskeletal disorders of childhood 
(13). The studies on the application of 
US in the assessment of joint involve-
ment in children affected by juvenile 
idiopathic arthritis (JIA) demonstrated 
a greater sensitivity in identifying joint 
synovitis than clinical examination 
alone (30-33). Despite the increasing 
application of US in the evaluation of 
paediatric rheumatic diseases, some 
limitations are still present. In particu-
lar, data about the validity and reliabil-
ity of US in the assessment of synovitis 
in JIA patients are missing (34). How-
ever, the assessment of musculo-skel-
etal US findings in children showed 
some difficulties. In particular, the 
physiologic modifications of structures 
in growing children and the presence 
of unossified immature skeleton could 
be misinterpreted as pathologic (35). 
Recently, a study conducted by Magni-
Manzoni et al. has reported data about 
US assessment of 39 healthy children, 
showing the presence of US abnormali-
ties on 35.9% of the cases (36). Specifi-
cally, SE was detected on 25.6% and 
SH on 12.8% of the enrolled children, 
in all the cases with a grade 1 (36). The 
results of the observation by Magni-
Manzoni et al. could be explained by 
the application of the OMERACT defi-
nitions for RA adult patients and by the 
need of a clear understanding of nor-
mal US anatomy of children joint.
Our results confirmed that joint symp-
toms may be present in CD and that 
they are mainly represented by arthral-
gia. However, the present study shows 
that US has an added value over clini-
cal examination, which is represented 
mainly by the possibility to detect ab-
normalities also in a relevant percent-
age of asymptomatic patients with CD. 
In these cases the most relevant find-
ing was represented by the detection of 
JE, which is one of the components of 
synovitis. Particularly, US assessment 
demonstrated that joint abnormalities 
can occur in almost 1/3 of patients, 
with JE representing the most frequent 
US finding and the knee the most fre-
quently involved joint compared with 
hips and ankles. In addition, our study 
pointed out that the prevalence of US 
abnormalities was significantly lower 
in children who started GFD than in 
those who were on a GCD. Therefore, 
these findings seem to confirm previ-
ous results and strengthen the hypoth-
esis that GFD could improve extra-
intestinal manifestations such as joint 
involvement (21).
In our patients, signs of structural chang-
es were never detected, as demonstrated 
by the absence of erosions and bone 
surface irregularities. This particular 
aspect seems to confirm the previously 
described non-aggressive joint involve-
ment in CD (6); however, further pro-
spective studies are needed to deepen 
these complex aspects of disease. 
The fact that we were able to identify 
subclinical synovitis by US supports 
the use of this imaging tool, being it 
more sensitive than physical examina-
tion in the detection of inflammatory 
joint abnormalities. This could be of 
value especially in paediatric patients, 
whose clinical examination could be 
sometimes difficult because of the poor 
compliance, the peculiar distribution 
of fat tissue and the difficulties in hav-
ing definite anatomical landmarks. The 
evaluation of our data did not show any 
significant correlation between the US-
detected abnormalities and histological 
features of CD. This result does not al-
low to identify a specific group of chil-
dren with higher risk to develop mus-
culoskeletal manifestations; however, 
an extensive joint US assessment may 
be recommended even in asympto-
matic CD patients. Finally, US is non-
invasive and well accepted by children 
modality, and could be the method of 
choice in the assessment of the inflam-
matory joint status in CD non-adult 
patients.
The present study showed some limita-
tions. Particularly, the lack of inclusion 
of healthy controls and the absence of 
a consensus between at least two ex-
perienced ultrasonographers should be 
reported as a major limit. However, the 
good results in terms of intraobserver 
reliability improve the results that were 
obtained. 
Conclusion
For the first time, we have shown that 
subclinical joint effusion is relatively 
frequent in children with CD and that 
GFD may reduce this manifestation. 
US may be considered a useful imag-
ing tool for identifying CD patients 
with subclinical synovitis. Further per-
spective studies are needed to clarify 
these issues.
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